BRACELET-1 results in HR+/HER2- metastatic breast cancer surpass expectations, providing meaningful data for a registration-enabling study Data from GOBLET in pancreatic ...
Hydrogen (H 2) is gaining attention for its potential role in sustainable practices and green technology. Research into the interaction of materials with hydrogen is critical for developing ...
Moleculin Biotech (MBRX) has received a Notice of Intent to Grant for the European patent application titled, “Method of Reconstituting Liposomal Annamycin”. The grant will enhance the global ...
The trucks, equipped with Hydrogen Internal Combustion Engines (H2-ICE) and Fuel Cell (H2-FCEV) technologies, will be tested on India's most prominent freight routes, including those around Mumbai, ...
Of course, with iPhones, you get all the benefits that the Apple H2 chip brings to AirPods – instant switching on all devices signed on to the same iCloud account, audio sharing with other Beats ...
In RIT’s biotechnology bachelor’s degree you’ll develop technologies for genetics, agriculture, pharmaceuticals, vaccine development, energy/ environment, forensics, and more. Hands on Experience: ...
The deal sees Lilly pay out $9 million upfront plus another $1 million after 15 months to the San Diego biotech, according to Securities and Exchange Commission (SEC) documents filed Feb.
In September, Akeso, a little-known Chinese biotech company founded nearly a decade ago shook up the biotech sector with its new lung cancer drug. Ivonescimab, the new drug, was found in a trial ...
Many bike enthusiasts turn to Kawasaki when searching for high-performance, high-quality bikes. The Japanese manufacturer has been churning out some big hitters in terms of speed and performance ...
The biotechnology sector’s foundations rest on basic scientific research. Early experiments done in academic laboratories often yield the discoveries that venture investors later form drug startups ...
Global biotech leader Amgen opened its $200 million technology and innovation centre in Hyderabad, a facility that will help the U.S. firm ramp up digital capabilities, open more opportunities for ...
An analyst queried Jack West, M.D., vice president of clinical development at Summit, about the biotech’s interest in combinations at an event in September. Noting that AstraZeneca and Merck are ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果